Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: A proposed genetic marker for coronary artery disease risk

Irish Journal of Medical Science

Volumn 169, Issue 1, 2000, Pages 50-54

  Sheehan, D ^a   Bennett, T ^a   Cashman, K ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRELAND; MALE; NORMAL HUMAN;

ADULT; AGED; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; IRELAND; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0034062742     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03170486     Document Type: Article

References (26)

1. Simopoulos AP. Genetic variation and nutrition. Nutr Today 1995;30:157-167.
2. Kannel WB, Castelli WP, Gordon T, Mcnamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham Study. Ann Intern Med 1971;74:1-12.
3. Ross R. The pathogenesis of atherosclerosis. In: Braunwald E (ed.) Heart Disease. WB Saunders, Philadelphia, pp 1135-1152.
4. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-2838.
5. Menotti A, Keys A, Aravanis C, Blackburn H, Dontas A, Fidanza F. Seven countries study. First 20-year mortality data in 12 cohorts of six countries. Ann Med 1989;21:175-179.
6. Gordon DJ, Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 1989;321:1311-1316.
7. Dammerman M, Breslow JL. Genetic basis of lipoprotein disorders. Circulation 1995;91:505-512.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
9. de Knijff P, van den Maagdenberg AMJM, Frants RR, Havekes LM. Genetic heterogenity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 1994;4:178-194.
10. Uttermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-440.
11. Cobbaert C, Mulder P. Regional serum cholesterol differences in Belgium: do genetically determined cardiovascular risk factors contribute? Int J Epidemiol 1998;27:605-613.
12. Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA, Cummings JH. Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br J Nutr 1998;79:133-139.
13. Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A. Influence of dietary fat, apolipoprotein-E phenotype, and sex on plasma lipoprotein levels. Circulation 1992;86:849-857.
14. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Varker F et al. Turkish heart study: lipids, lipoproteins and apolipoproteins. J Lipid Res 1995;36:839-859.
15. de Knijff P, Havekes LM. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr Opin Lipidol 1996; 7:59-63.
16. Gathof BS, Schreiber MA, Gresser U, Kamilli I, Zollner N Importance of the confounding factors age and sex in the correlation of serum uric acid, cholesterol and triglyceride levels. Adv Exp Med Biol 1991;309A:231-234.
17. Simpson JM, Brennan PJ, McGilchrist CA, Blacket RB The inheritance of serum cholesterol: adjustment of observed cholesterol levels for age, sex and body weight using inverse-polynomial regression. Int J Epidemiol 1982 11:76-81.
18. Whitehead AS, Bertrandy S, Finnan F, Butler A, Smith GD, Ben-Shlomo Y. Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. J Neurol Neurosurg Psychiatry 1996; 61:347-51.
19. Hallman MD, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
20. Boer JMA, Ehnholm C, Menzel HJ, Havekes LM, Rosseneu M, O'Reilly DJ, Tiret L. Interactions between lifestyle-related factors and the Apo E polymorphism on the plasma lipids and apolipoproteins. Arterioscler Thromb Vasc Biol 1997;17:1675-1681.
21. Pablos-Mendez A, Mayeux R, Ngai C, Shea S, Berglund L. Association of Apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997;173:534-3541.
22. Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E. Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin Genet 1995;47:1-12.
23. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglycerides levels by apoE phenotype: a meta-analysis. J Lipid Res 1992;33:447-454.
24. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
25. de Knijff P, Kaptein A, Boomsma D, Princen HM, Frants RR, Havekes LM. Apolipoprotein E polymorphism affects plasma levels of lipoprotein (a). Artherosclerosis 1991;90:169-174.
26. Simopoulos AP. Diet and gene interactions. Food Technology 1997;51:66-69.